DJIA 18,096.90 -106.47 -0.58%
NASDAQ 4,967.14 -12.76 -0.26%
S&P 500 2,098.53 -9.25 -0.44%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

70.16 1.50 (2.18%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $70.16 2.18%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $68.21
Previous Close $68.66
Daily Range $67.00 - $70.83
52-Week Range $22.25 - $75.24
Market Cap $8.4B
P/E Ratio -208.06
Dividend (Yield) $0.00 (0.0%)
Volume 2,740,382
Average Daily Volume 3,057,670
Current FY EPS -$1.12




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary

Pfizer Inc. Has a Growth Problem -- Here Are 3 Ways to Change That

This year will likely mark Pfizer's fifth consecutive year of revenue declines. But a quick solution to its growth concerns could lie within one (or more) of these three proposed fixes.

Biotech Stock Roundup: Orexigen Soars on Contrave Data, Amgen Scores in Study - Analyst Blog

Roche's Avastin Gets Positive Opinion for Cervical Cancer - Analyst Blog

Gilead's (GILD) HIV Drug Positive in 2 Phase III Studies - Analyst Blog

3 Stocks Dragging The Drugs Industry Downward

Morning Market Losers

Isis Pharmaceuticals (ISIS) Is Today's Unusual Social Activity Stock

Health Care Sector Update for 03/02/2015: PCRX, ISIS, XLRN

Benzinga's Top #PreMarket Losers

Whoa, a Profit for Isis Pharmaceuticals Inc.

Don't get too excited just yet.

See More ISIS News...

ISIS's Top Competitors

ISIS $70.16 (2.18%)
Current stock: ISIS
AMGN $159.19 (0.40%)
Current stock: AMGN
GILD $103.06 (0.26%)
Current stock: GILD
BIIB $414.13 (0.32%)
Current stock: BIIB